Colgate-Palmolive (NYSE:CL) Shares Sold by Bank of Montreal Can

Bank of Montreal Can reduced its stake in Colgate-Palmolive (NYSE:CL) by 27.8% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,681,891 shares of the company’s stock after selling 646,097 shares during the period. Bank of Montreal Can owned approximately 0.21% of Colgate-Palmolive worth $174,345,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of CL. 1832 Asset Management L.P. grew its holdings in Colgate-Palmolive by 4,847.3% during the 1st quarter. 1832 Asset Management L.P. now owns 9,301 shares of the company’s stock worth $838,000 after acquiring an additional 9,113 shares in the last quarter. B. Riley Wealth Advisors Inc. grew its stake in shares of Colgate-Palmolive by 0.8% during the first quarter. B. Riley Wealth Advisors Inc. now owns 16,639 shares of the company’s stock worth $1,498,000 after purchasing an additional 138 shares in the last quarter. California State Teachers Retirement System increased its holdings in Colgate-Palmolive by 0.8% in the first quarter. California State Teachers Retirement System now owns 1,301,518 shares of the company’s stock valued at $117,202,000 after buying an additional 9,979 shares during the last quarter. Tidal Investments LLC raised its stake in Colgate-Palmolive by 31.1% in the first quarter. Tidal Investments LLC now owns 61,646 shares of the company’s stock valued at $5,551,000 after buying an additional 14,631 shares in the last quarter. Finally, Hancock Whitney Corp lifted its holdings in Colgate-Palmolive by 1.3% during the 1st quarter. Hancock Whitney Corp now owns 12,017 shares of the company’s stock worth $1,082,000 after buying an additional 151 shares during the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.37% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

CL has been the topic of several research analyst reports. Sanford C. Bernstein raised their target price on Colgate-Palmolive from $100.00 to $103.00 and gave the stock a “market perform” rating in a research report on Tuesday, July 30th. UBS Group raised their price objective on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the stock a “buy” rating in a report on Wednesday, September 4th. Morgan Stanley upped their target price on shares of Colgate-Palmolive from $103.00 to $111.00 and gave the company an “overweight” rating in a report on Monday, July 29th. JPMorgan Chase & Co. lifted their price target on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Finally, Barclays upped their price objective on shares of Colgate-Palmolive from $91.00 to $96.00 and gave the company an “equal weight” rating in a research note on Monday, July 29th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have assigned a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $105.11.

Colgate-Palmolive Price Performance

Shares of CL opened at $95.34 on Tuesday. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. The stock’s 50 day moving average is $97.90 and its two-hundred day moving average is $98.58. Colgate-Palmolive has a twelve month low of $75.50 and a twelve month high of $109.30. The firm has a market capitalization of $77.89 billion, a PE ratio of 27.32, a P/E/G ratio of 3.39 and a beta of 0.42.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were given a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.10%. The ex-dividend date of this dividend was Friday, October 18th. Colgate-Palmolive’s payout ratio is 57.31%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.